Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8

被引:64
作者
Carbone, A
Cilia, AM
Gloghini, A
Capello, D
Todesco, M
Quattrone, S
Volpe, R
Gaidano, G
机构
[1] Ctr Riferimento Oncol, IRCCS, Ist Nazl Tumori, Div Pathol, I-33081 Aviano, Italy
[2] Univ Turin, Dept Med Sci, Div Internal Med, Novara, Italy
关键词
primary effusion lymphoma cell lines; HHV-8-positive primary effusion lymphoma cell lines; AIDS-related non-Hodgkin's lymphoma; HHV-8; infection; EBV infection;
D O I
10.1046/j.1365-2141.1998.00877.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we report on the establishment and characterization of two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) which carry infection by human herpesvirus type-8 (HHV-8) and have derived from AIDS-related primary effusion lymphoma (PEL). These two cell lines are representative of different virologic subtypes of PEL, i.e. HHV-8(+)/EBV- PEL in the case of CRO-AP/3 and HHV-8(+)/EBV+ PEL in the case of CRO-AP/5. Consistent with the diagnosis of PEL, both CRO-AP/3 and CRO-AP/5 expressed indeterminate (i.e. non-B, non-T) phenotypes although immunogenotypic studies documented their B-cell origin, Both cell lines are devoid of genetic lesions of c-MYC, BCL-2 and p53 as well as gross rearrangements of BCL-6. Detailed histogenetic characterization of these novel PEL cell lines suggests that PEL may derive from a post-germinal centre B cell which has undergone pre-terminal differentiation. The CRO-AP/3 and CRO-AP/5 cell lines may provide a valuable model for clarifying the pathogenesis of PEL. In particular, these cell lines may help understand the relative contribution of HHV-8 and EBV to PEL growth and development and may facilitate the identification of recurrent cytogenetic abnormalities highlighting putative novel cancer related loci relevant to PEL.
引用
收藏
页码:1081 / 1089
页数:9
相关论文
共 35 条
[1]   Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus [J].
Arvanitakis, L ;
Mesri, EA ;
Nador, RG ;
Said, JW ;
Asch, AS ;
Knowles, DM ;
Cesarman, E .
BLOOD, 1996, 88 (07) :2648-2654
[2]  
BALLERINI P, 1993, BLOOD, V81, P166
[3]   Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice [J].
Boshoff, C ;
Gao, SJ ;
Healy, LE ;
Matthews, S ;
Thomas, AJ ;
Coignet, L ;
Warnke, RA ;
Strauchen, JA ;
Matutes, E ;
Kamel, OW ;
Moore, PS ;
Weiss, RA ;
Chang, Y .
BLOOD, 1998, 91 (05) :1671-1679
[4]  
Carbone A, 1997, AM J PATHOL, V150, P155
[5]   Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions [J].
Carbone, A ;
Gloghini, A ;
Vaccher, E ;
Zagonel, V ;
Pastore, C ;
DallaPalma, P ;
Branz, F ;
Saglio, G ;
Volpe, R ;
Tirelli, U ;
Gaidano, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) :533-543
[6]  
Carbone A, 1997, INT J CANCER, V73, P562, DOI 10.1002/(SICI)1097-0215(19971114)73:4&lt
[7]  
562::AID-IJC18&gt
[8]  
3.0.CO
[9]  
2-B
[10]   HHV-8-positive body-cavity-based lymphoma: A novel lymphoma entity [J].
Carbone, A ;
Gaidano, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) :515-522